Table 4.
Patients’ side effects of chemotherapy for all patients according to programmed cell death ligand-1 (PD-L1).
| n | level | Low PD-L1 | High PD-L1 | P |
|---|---|---|---|---|
| 61 | 43 | |||
| Decreased appetite (%) | No | 10 (16.4) | 7 (16.3) | 1.000 |
| Yes | 51 (83.6) | 36 (83.7) | ||
| Nausea (%) | No | 7 (11.5) | 4 (9.3) | 0.975 |
| Yes | 54 (88.5) | 39 (90.7) | ||
| Vomiting (%) | No | 32 (52.5) | 18 (41.9) | 0.386 |
| Yes | 29 (47.5) | 25 (58.1) | ||
| Diarrhea (%) | No | 57 (93.4) | 40 (93.0) | 1.000 |
| Yes | 4 (6.6) | 3 (7.0) | ||
| Mouth ulcers (%) | No | 60 (98.4) | 42 (97.7) | 1.000 |
| Yes | 1 (1.6) | 1 (2.3) | ||
| Alopecia (%) | No | 29 (47.5) | 19 (44.2) | 0.890 |
| Yes | 32 (52.5) | 24 (55.8) | ||
| Peripheral neurotoxicity (%) | No | 48 (78.7) | 39 (90.7) | 0.173 |
| Yes | 13 (21.3) | 4 (9.3) | ||
| Anemia (%) | Grade 0 | 34 (55.7) | 21 (48.8) | 0.621 |
| Grade 1-2 | 27 (44.3) | 22 (51.2) | ||
| Leukopenia (%) | Grade 0 | 12 (19.7) | 12 (27.9) | 0.502 |
| Grade 1-2 | 35 (57.4) | 20 (46.5) | ||
| Grade 3-4 | 14 (23.0) | 11 (25.6) | ||
| Neutropenia (%) | Grade 0 | 8 (13.1) | 12 (27.9) | 0.157 |
| Grade 1-2 | 25 (41.0) | 16 (37.2) | ||
| Grade 3-4 | 28 (45.9) | 15 (34.9) | ||
| Thrombocytopenia (%) | Grade 0 | 49 (80.3) | 30 (69.8) | 0.313 |
| Grade 1-2 | 12 (19.7) | 13 (30.2) | ||
| Gastrointestinal reaction (%) | Grade 0 | 7 (11.5) | 5 (11.6) | 0.701 |
| Grade 1-2 | 53 (86.9) | 38 (88.4) | ||
| Grade 3-4 | 1 (1.6) | 0 (0.0) | ||
| Myelosuppression (%) | Grade 0 | 5 (8.2) | 10 (23.3) | 0.096 |
| Grade 1-2 | 20 (32.8) | 11 (25.6) | ||
| Grade 3-4 | 36 (59.0) | 22 (51.2) | ||
| Hepatic dysfunction (%) | Grade 0 | 42 (68.9) | 24 (55.8) | 0.249 |
| Grade 1-2 | 19 (31.1) | 19 (44.2) |